Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Medtronic
Daiichi Sankyo
Teva
Mallinckrodt
Dow
UBS
Fuji
Healthtrust

Generated: May 25, 2018

DrugPatentWatch Database Preview

Flurandrenolide; neomycin sulfate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for flurandrenolide; neomycin sulfate and what is the scope of flurandrenolide; neomycin sulfate patent protection?

Flurandrenolide; neomycin sulfate
is the generic ingredient in one branded drug marketed by Lilly and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for flurandrenolide; neomycin sulfate.
Summary for flurandrenolide; neomycin sulfate
US Patents:0
Tradenames:1
Applicants:1
NDAs:2
Drug Master File Entries: 4
Clinical Trials: 682
DailyMed Link:flurandrenolide; neomycin sulfate at DailyMed

US Patents and Regulatory Information for flurandrenolide; neomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly CORDRAN N flurandrenolide; neomycin sulfate CREAM;TOPICAL 050346-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly CORDRAN N flurandrenolide; neomycin sulfate OINTMENT;TOPICAL 050345-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Healthtrust
Cipla
Harvard Business School
Chinese Patent Office
Citi
US Army
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.